Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common / Ordinary Stock
-
Total 13F shares
-
4,219,809
-
Share change
-
+116,745
-
Total reported value
-
$317,150,000
-
Price per share
-
$75.45
-
Number of holders
-
98
-
Value change
-
+$7,262,561
-
Number of buys
-
45
-
Number of sells
-
38
Institutional Holders of Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) as of Q3 2019
As of 30 Sep 2019,
Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,219,809 shares.
The largest 10 holders included
FMR LLC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, APG Asset Management N.V., NORGES BANK, Invesco Ltd., ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, ROYAL BANK OF CANADA, and CLARET ASSET MANAGEMENT Corp.
This page lists
98
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.